Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination.

Zhao W, Li Q, Ayers S, Gu Y, Shi Z, Zhu Q, Chen Y, Wang HY, Wang RF.

Cell. 2013 Feb 28;152(5):1037-50. doi: 10.1016/j.cell.2013.02.006.

2.

Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.

Barradas M, Anderton E, Acosta JC, Li S, Banito A, Rodriguez-Niedenführ M, Maertens G, Banck M, Zhou MM, Walsh MJ, Peters G, Gil J.

Genes Dev. 2009 May 15;23(10):1177-82. doi: 10.1101/gad.511109.

3.

Cell-free extract from porcine induced pluripotent stem cells can affect porcine somatic cell nuclear reprogramming.

No JG, Choi MK, Kwon DJ, Yoo JG, Yang BC, Park JK, Kim DH.

J Reprod Dev. 2015;61(2):90-8. doi: 10.1262/jrd.2014-078. Epub 2015 Jan 24.

4.

The Ink4/Arf locus is a barrier for iPS cell reprogramming.

Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, Blasco MA, Serrano M.

Nature. 2009 Aug 27;460(7259):1136-9. doi: 10.1038/nature08290. Epub 2009 Aug 9.

5.

Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process.

Salminen A, Kaarniranta K, Hiltunen M, Kauppinen A.

J Mol Med (Berl). 2014 Oct;92(10):1035-43. doi: 10.1007/s00109-014-1182-x. Epub 2014 Jun 14. Review.

PMID:
24925089
6.

Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency.

Sridharan R, Gonzales-Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel S, Lopez D, Mishra N, Pellegrini M, Carey M, Garcia BA, Plath K.

Nat Cell Biol. 2013 Jul;15(7):872-82. doi: 10.1038/ncb2768. Epub 2013 Jun 9.

7.

Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.

Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M, Djabali M.

PLoS One. 2009 May 20;4(5):e5622. doi: 10.1371/journal.pone.0005622.

8.

JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.

Xun J, Wang D, Shen L, Gong J, Gao R, Du L, Chang A, Song X, Xiang R, Tan X.

Oncotarget. 2017 Mar 28;8(13):21918-21929. doi: 10.18632/oncotarget.15747.

9.

Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.

Huang HP, Chen PH, Yu CY, Chuang CY, Stone L, Hsiao WC, Li CL, Tsai SC, Chen KY, Chen HF, Ho HN, Kuo HC.

J Biol Chem. 2011 Sep 23;286(38):33520-32. doi: 10.1074/jbc.M111.256164. Epub 2011 Jul 28.

10.

The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence.

Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, Helin K.

Genes Dev. 2009 May 15;23(10):1171-6. doi: 10.1101/gad.510809.

11.

Global epigenetic changes during somatic cell reprogramming to iPS cells.

Mattout A, Biran A, Meshorer E.

J Mol Cell Biol. 2011 Dec;3(6):341-50. doi: 10.1093/jmcb/mjr028. Epub 2011 Nov 1.

PMID:
22044880
12.

The dosage of Patz1 modulates reprogramming process.

Ma H, Ow JR, Tan BC, Goh Z, Feng B, Loh YH, Fedele M, Li H, Wu Q.

Sci Rep. 2014 Dec 17;4:7519. doi: 10.1038/srep07519.

13.

Activation of neuronal gene expression by the JMJD3 demethylase is required for postnatal and adult brain neurogenesis.

Park DH, Hong SJ, Salinas RD, Liu SJ, Sun SW, Sgualdino J, Testa G, Matzuk MM, Iwamori N, Lim DA.

Cell Rep. 2014 Sep 11;8(5):1290-9. doi: 10.1016/j.celrep.2014.07.060. Epub 2014 Aug 28.

14.

p53 interaction with JMJD3 results in its nuclear distribution during mouse neural stem cell differentiation.

Solá S, Xavier JM, Santos DM, Aranha MM, Morgado AL, Jepsen K, Rodrigues CM.

PLoS One. 2011 Mar 31;6(3):e18421. doi: 10.1371/journal.pone.0018421.

15.

Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells.

Wang Q, Xu X, Li J, Liu J, Gu H, Zhang R, Chen J, Kuang Y, Fei J, Jiang C, Wang P, Pei D, Ding S, Xie X.

Cell Res. 2011 Oct;21(10):1424-35. doi: 10.1038/cr.2011.108. Epub 2011 Jul 5.

16.

Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome.

Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM.

Mol Cell. 2007 Jun 22;26(6):843-52.

17.

Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming.

Hu X, Zhang L, Mao SQ, Li Z, Chen J, Zhang RR, Wu HP, Gao J, Guo F, Liu W, Xu GF, Dai HQ, Shi YG, Li X, Hu B, Tang F, Pei D, Xu GL.

Cell Stem Cell. 2014 Apr 3;14(4):512-22. doi: 10.1016/j.stem.2014.01.001. Epub 2014 Feb 13.

18.

Proteomic changes induced by histone demethylase JMJD3 in TNF alpha-treated human monocytic (THP-1) cells.

Das A, Das ND, Jung KH, Park JH, Lee HT, Han D, Choi MR, Kang SC, Chai YG.

Mol Immunol. 2013 Nov;56(1-2):113-22. doi: 10.1016/j.molimm.2013.04.013. Epub 2013 May 25.

PMID:
23711388
19.

Histone demethylase JMJD3 at the intersection of cellular senescence and cancer.

Perrigue PM, Najbauer J, Barciszewski J.

Biochim Biophys Acta. 2016 Apr;1865(2):237-44. doi: 10.1016/j.bbcan.2016.03.002. Epub 2016 Mar 5. Review.

PMID:
26957416
20.

Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.

Kim JS, Choi HW, Choi S, Seo HG, Moon SH, Chung HM, Do JT.

Stem Cells Dev. 2014 Nov 1;23(21):2637-48. doi: 10.1089/scd.2014.0020. Epub 2014 Aug 20.

Supplemental Content

Support Center